Sun Pharmaceutical Industries Ltd. | SUNPHARMA | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2017
2018
2019
2020
2021
Revenue
Revenue
315,784264,895290,659328,375334,981
Cost of revenue
Cost of revenue
-81,307-74,247-78,690-92,305-86,901
Gross Profit
Gross Profit
234,477
190,648
211,969
236,071
248,081
Sales, general & ad...
Sales, general and administrative
-133,584-134,567-148,894-166,329-163,403
Depreciation
Depreciation and amortization
-12,648-14,998-17,533-20,528-20,800
Provision
Provision
00000
Other op inc/exp...
Other operating income/expenses
0001560
Operating income
Operating income EBIT
88,245
41,083
45,543
49,370
63,878
 
      
Interest expense
Interest expense
-3,998-5,176-5,553-3,027-1,414
Other income/exp...
Other income(expense)
6,232-1,117-1,8893,753-34,706
Profit before tax
Profit before tax
90,479
34,790
38,102
50,096
27,757
Income tax & other ta...
Income tax and other taxes
12,1168,4526,0098,2285,147
Net income from c...
Net income from continuing operations
78,36326,33832,09341,86822,610
Extraordinary & disc...
Extraordinary items & Discontinued Ops
00000
Share of associates
Share of associates
99-254-15-148-123
Minority Interest
Minority Interest
-8,819-4,468-5,424-4,0706,315
Net Income
Net income
69,644
21,616
26,654
37,649
28,802
 
      
NI - Preferred Di...
Net Income after Preferred Dividend and Others
69,64421,61626,65437,64928,802
Basic shares
Basic shares
2,4032,3992,3992,3992,399
Diluted Shares
Diluted Shares
2,4042,3992,3992,3992,399
EPS Basic
EPS Basic in Rupees
28.989.0111.1115.6912.00
EPS Diluted
EPS Diluted in Rupees
28.98
9.01
11.11
15.69
12.00